Published 4 years ago • loading... • Updated 4 years ago
U.S. FDA removes COVID test requirements for Pfizer, Merck pills
Summary by Ground News
Pfizer's Paxlovid and Merck's Lagevrio pills were given emergency use authorizations in Dec. 2021. FDA said the patients should have a current diagnosis of mild-to-moderate COVID infection. Individuals with recent known exposure with signs and symptoms may be diagnosed by their healthcare providers with COVID even if they have a negative test result.